Abiraterone acetate 500 MG Oral Tablet — RxCUI 1918042
RxNorm drug concept · Semantic clinical drug
RxCUI 1918042
Semantic clinical drug · SCD
● Current RxNorm concept 26 FDA products
31 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1918042
Official nameAbiraterone acetate 500 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped26
Package NDCs mapped31
Reported Medicaid activity (SDUD)12,182 prescriptions · 37 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Abiraterone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats prostate cancer that has spread. Abiraterone acetate tablets, Abirtega and Zytiga are used for metastatic castration-resistant and metastatic high-risk castration-sensiti...
- Take it once a day and swallow the tablets whole with water. With abiraterone acetate tablets, Abirtega or Zytiga, don't eat for 2 hours before or 1 hour after your dose, because f...
- How should I take it, and does food matter?
- Abiraterone can cause a hormone imbalance, leading to high blood pressure, low potassium and fluid retention. The steroid is part of your treatment. Don't skip it or stop suddenly,...
🕸️ Concept Web — How Abiraterone acetate 500 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Abiraterone acetate 500 MG Oral Tablet
RxCUI 1918042 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Abiraterone
1100072IN -
Abiraterone acetate
1100071PIN
-
Abiraterone
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zytiga
1100076BN
-
Zytiga
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Abiraterone Oral Tablet
1100074SCDF -
Abiraterone acetate Oral Tablet
2646523SCDFP -
Abiraterone Oral Product
1163656SCDG -
Abiraterone Pill
1163657SCDG -
Abiraterone acetate Oral Product
2661457SCDGP -
Abiraterone acetate Pill
2662678SCDGP -
Abiraterone Oral Tablet [Zytiga]
1100078SBDF -
Abiraterone acetate Oral Tablet [Zytiga]
2655185SBDFP - +5 more in this family
-
Abiraterone Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Abiraterone acetate 500 MG
1918041SCDC -
Abiraterone acetate 500 MG Oral Tablet [Zytiga]
1918044SBD -
Abiraterone acetate 500 MG [Zytiga]
1918043SBDC
-
Abiraterone acetate 500 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Abiraterone acetate 500 MG
SCDC · 1918041 -
Abiraterone Oral Tablet
SCDF · 1100074 -
Abiraterone acetate Oral Tablet
SCDFP · 2646523 -
Abiraterone Oral Product
SCDG · 1163656 -
Abiraterone Pill
SCDG · 1163657 -
Abiraterone acetate Oral Product
SCDGP · 2661457 -
Abiraterone acetate Pill
SCDGP · 2662678
Brand-Name Concepts
-
Abiraterone acetate 500 MG Oral Tablet [Zytiga]
SBD · 1918044 -
Abiraterone acetate 500 MG [Zytiga]
SBDC · 1918043 -
Abiraterone Oral Tablet [Zytiga]
SBDF · 1100078 -
Abiraterone acetate Oral Tablet [Zytiga]
SBDFP · 2655185 -
Zytiga Oral Product
SBDG · 1186683 -
Zytiga Pill
SBDG · 1186684 -
Zytiga
BN · 1100076
📦 FDA Products & Package NDCs
26 products · 31 package NDCs
31 package NDCs map to RxCUI 1918042 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-6920-78 | 120 TABLET in 1 BOTTLE, PLASTIC (0378-6920-78) | Abiraterone Acetate | Mylan Pharmaceuticals Inc. | 2018-11-21 |
| 00378-6921-91 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-6921-91) | Abiraterone Acetate | Mylan Pharmaceuticals Inc. | 2020-12-14 |
| 43598-0358-04 | 120 TABLET in 1 BOTTLE (43598-358-04) | Abiraterone Acetate | Dr. Reddys Laboratories Inc | 2020-05-19 |
| 43598-0358-31 | 3 BLISTER PACK in 1 CARTON (43598-358-31) / 10 TABLET in 1... | Abiraterone Acetate | Dr. Reddys Laboratories Inc | 2021-12-20 |
| 43598-0468-38 | 6 BLISTER PACK in 1 CARTON (43598-468-38) / 10 TABLET in 1... | Abiraterone Acetate | Dr. Reddys Laboratories Inc | 2023-09-11 |
| 43598-0468-60 | 60 TABLET in 1 BOTTLE (43598-468-60) | Abiraterone Acetate | Dr. Reddys Laboratories Inc | 2023-09-11 |
| 57894-0150-12 | 120 TABLET in 1 BOTTLE (57894-150-12) | Zytiga | Janssen Biotech, Inc. | 2011-04-28 |
| 57894-0195-06 | 60 TABLET, FILM COATED in 1 BOTTLE (57894-195-06) | Zytiga | Janssen Biotech, Inc. | 2017-04-17 |
| 57894-0195-15 | 60 TABLET, FILM COATED in 1 BOTTLE (57894-195-15) | Zytiga | Janssen Biotech, Inc. | 2017-04-17 |
| 60219-1165-07 | 120 TABLET in 1 BOTTLE (60219-1165-7) | Abiraterone Acetate | Amneal Pharmaceuticals NY LLC | 2023-04-28 |
| 60219-1754-06 | 60 TABLET in 1 BOTTLE (60219-1754-6) | ABIRATERONE ACETATE | Amneal Pharmaceuticals NY LLC | 2023-04-28 |
| 60505-4764-06 | 60 TABLET, FILM COATED in 1 BOTTLE (60505-4764-6) | abiraterone acetate | Apotex Corp. | 2021-07-16 |
| 68001-0489-07 | 120 TABLET in 1 BOTTLE (68001-489-07) | Abiraterone | BluePoint Laboratories | 2021-02-26 |
| 68001-0673-06 | 60 TABLET in 1 BOTTLE (68001-673-06) | Abiraterone | BluePoint Laboratories | 2025-10-16 |
| 68462-0135-08 | 120 TABLET in 1 BOTTLE (68462-135-08) | abiraterone acetate | Glenmark Pharmaceuticals Inc., USA | 2019-10-16 |
| 68462-0882-60 | 60 TABLET in 1 BOTTLE (68462-882-60) | abiraterone acetate | Glenmark Pharmaceuticals Inc., USA | 2022-05-19 |
| 69238-1165-07 | 120 TABLET in 1 BOTTLE (69238-1165-7) | Abiraterone Acetate | Amneal Pharmaceuticals NY LLC | 2019-01-07 |
| 69238-1754-06 | 60 TABLET in 1 BOTTLE (69238-1754-6) | ABIRATERONE ACETATE | Amneal Pharmaceuticals NY LLC | 2019-01-07 |
| 71921-0177-06 | 60 TABLET, FILM COATED in 1 BOTTLE (71921-177-06) | Abiraterone acetate | Florida Pharmaceutical Products, LLC | 2023-04-10 |
| 72162-2151-06 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72162-2151-6) | Abiraterone Acetate | Bryant Ranch Prepack | 2023-12-07 |
| 72205-0030-92 | 120 TABLET in 1 BOTTLE (72205-030-92) | Abiraterone | Novadoz Pharmaceuticals LLC | 2019-07-10 |
| 72205-0284-05 | 500 TABLET, FILM COATED in 1 BOTTLE (72205-284-05) | Abiraterone | Novadoz Pharmaceuticals LLC | 2024-05-24 |
| 72205-0284-92 | 120 TABLET, FILM COATED in 1 BOTTLE (72205-284-92) | Abiraterone | Novadoz Pharmaceuticals LLC | 2024-05-24 |
| 72205-0285-05 | 500 TABLET, FILM COATED in 1 BOTTLE (72205-285-05) | Abiraterone | Novadoz Pharmaceuticals LLC | 2024-05-24 |
| 72205-0285-60 | 60 TABLET, FILM COATED in 1 BOTTLE (72205-285-60) | Abiraterone | Novadoz Pharmaceuticals LLC | 2024-05-24 |
| 72603-0110-01 | 120 TABLET in 1 BOTTLE (72603-110-01) | abiraterone acetate | NORTHSTAR RX LLC | 2022-03-07 |
| 72603-0111-01 | 60 TABLET in 1 BOTTLE (72603-111-01) | abiraterone acetate | NORTHSTAR RX LLC | 2022-05-19 |
| 82009-0139-12 | 120 TABLET in 1 BOTTLE (82009-139-12) | Abiraterone | Quallent Pharmaceuticals Health LLC | 2024-06-15 |
| 82009-0140-60 | 60 TABLET, FILM COATED in 1 BOTTLE (82009-140-60) | Abiraterone | Quallent Pharmaceuticals Health LLC | 2024-07-16 |
| 82293-0001-10 | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82293-001-10) | Abiraterone Acetate | Novugen Pharma (USA) LLC | 2022-01-05 |
| 82293-0002-10 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82293-002-10) | Abiraterone Acetate | Novugen Pharma (USA) LLC | 2022-01-05 |
Observed labelers:
Novadoz Pharmaceuticals LLC (5) ·
Amneal Pharmaceuticals NY LLC (4) ·
Dr. Reddys Laboratories Inc (4) ·
Janssen Biotech, Inc. (3) ·
BluePoint Laboratories (2) ·
Glenmark Pharmaceuticals Inc., USA (2)
· +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.